LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Journal Information
Full Title: Cancer Biol Ther
Abbreviation: Cancer Biol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure statement All authors agree with the presented findings, have contributed to the work, and declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"Authors’ contributions: Huiyong Chen: Conceptualization; Methodology; Validation;: Linhui Wang: Formal analysis; Investigation; Resources;: Jingting Liu: Data Curation;: Zihao Wan: Writing – Original Draft;: Lin Zhou: Visualization;: Hongliang Liao: Writing – Review & Editing;: Renping Wan: Supervision; Project administration; Funding acquisition"
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025